Spinal astrocytic c-Jun N-terminal kinase (JNK) activation as counteracting mechanism to the amitriptyline analgesic efficacy in painful peripheral neuropathies
- 1 March 2017
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 798, 85-93
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Selective modulation of the PKCɛ/p38MAP kinase signalling pathway for the antidepressant-like activity of amitriptylineNeuropharmacology, 2012
- JNK-Induced MCP-1 Production in Spinal Cord Astrocytes Contributes to Central Sensitization and Neuropathic PainThe Journal of Neuroscience, 2009
- Amitriptyline induces early growth response-1 gene expression via ERK and JNK mitogen-activated protein kinase pathways in rat C6 glial cellsNeuroscience Letters, 2007
- EFNS guidelines on pharmacological treatment of neuropathic painEuropean Journal of Neurology, 2006
- Diabetes-Induced Mechanical Hyperalgesia Involves Spinal Mitogen-Activated Protein Kinase Activation in Neurons and Microglia via N-Methyl-D-aspartate-Dependent MechanismsMolecular Pharmacology, 2006
- Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mousePain, 2006
- Algorithm for neuropathic pain treatment: An evidence based proposalPain, 2005
- Differential Analgesic Sensitivity of Two Distinct Neuropathic Pain ModelsAnesthesia & Analgesia, 2004
- Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/HyperalgesiaThe Neuroscientist, 2004
- A procedure for direct lumbar puncture in ratsBrain Research Bulletin, 2002